President Trump issued a memorandum to address what he claims is excessive and wasteful spending in the Medicaid program.

The memorandum directs the Secretary of Health and Human Services to take action to eliminate waste, fraud, and abuse within Medicaid and to align Medicaid payment rates with those of Medicare—a move the president characterizes as necessary to protect the financial stability of both programs and ensure access to care for seniors and vulnerable groups.

The President contends that the Biden administration enabled states to circumvent cost controls resulting in unsustainable spending.

President's order implements automatic spending cuts, or sequestration, of the federal budget for Fiscal Year 2026.

The order is based on the Balanced Budget and Emergency Deficit Control Act, referencing the Office of Management and Budget's May 30, 2025 report to determine the amount of budget reductions for each non-exempt account, effective October 1, 2025.

The cuts must adhere strictly to the Act's requirements and the OMB report specifications.

President Trump issued a memorandum directing the Attorney General, in consultation with the Secretary of the Treasury, to fully investigate alleged misuse of online fundraising platforms for illegal campaign contributions.

The investigation will focus on schemes involving 'straw donors' and foreign nationals attempting to circumvent campaign finance laws.

The Attorney General is required to submit a report on the findings within six months.

This executive order establishes the White House Initiative on Historically Black Colleges and Universities (HBCUs).

The initiative aims to bolster HBCUs by increasing private-sector involvement, fostering public-private partnerships, improving access to federal funding, strengthening their administrative capacities, and promoting innovation and excellence in research and education.

It also creates a President's Board of Advisors on HBCUs and revokes previous related executive orders.

This Presidential Action addresses the lack of transparency surrounding foreign funding in American higher education institutions.

It directs the Secretary of Education to strengthen enforcement of existing disclosure laws, reverse steps that previously hindered transparency, and ensure that compliance is a condition for receiving federal grants.

The goal is to protect national security interests, academic integrity, and the marketplace of ideas from foreign influence.

This April 17, 2025, presidential memorandum extends a freeze on hiring for federal civilian employees through July 15, 2025.

The freeze applies to all executive branch agencies, barring exceptions for national security, public safety, immigration enforcement and essential services.

Future hiring must comply with a merit-based hiring plan.

Contracting to circumvent the freeze is prohibited, and agencies are instructed to use existing personnel efficiently.

The memorandum also does not affect the deadline for a plan to reduce the federal workforce.

Exceptions may be granted by the Office of Personnel Management (OPM).

The freeze will remain in effect for the IRS until the Treasury Secretary determines otherwise and publishes a notice in the Federal Register.

President Trump issued an order to reduce wasteful government spending by requiring federal agencies to favor commercially available products and services whenever possible.

The order directs agencies to review existing contracts and procurement processes, requiring justifications for using non-commercial options.

Agencies must report their progress to the Office of Management and Budget (OMB), ensuring accountability and promoting efficient use of taxpayer dollars.

President Trump's executive order aims to significantly lower prescription drug prices for Americans.

The order criticizes the Inflation Reduction Act for insufficient savings and negative impacts on seniors' healthcare coverage.

To address this, the order directs various federal agencies to take actions like reforming Medicare drug price negotiations, stabilizing Part D premiums, and better controlling middleman prescription drug markups.

It also seeks to increase competition by accelerating generic drug approvals and streamlining drug importation.